Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
Eric L SimpsonPablo Fernández-PeñasMarjolein de Bruin-WellerPeter A LioChia-Yu ChuKhaled EzzedineHelena AgellMarta CasillasYuxin DingFan Emily YangEvangeline PierceThomas BieberPublished in: Advances in therapy (2024)
ClinicalTrials.gov identifiers, NCT04146363; NCT04178967.